Meiji Seika Pharma launches first-in-human trial of Novel PD-1 agonist for autoimmune diseases
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
Experts caution that realizing AI’s potential requires careful management and risk mitigation
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
AbbVie will offer reduced prices for its medicines in Medicaid and commit $100 billion over the next decade to US research, development and capital investments, including domestic manufacturing
The decision secures legal protection in China for semaglutide, the blockbuster drug underpinning Novo Nordisk’s diabetes and obesity treatments
Clinical trials found that 77% of patients went into remission after receiving obe-cel
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
Subscribe To Our Newsletter & Stay Updated